Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.
作者信息
van de Donk Niels W C J, Bahlis Nizar, Costa Luciano J, Mateos María-Victoria, Nooka Ajay K, Perrot Aurore, Garfall Alfred L, Thaman Pragya, Qi Keqin, Uhlar Clarissa, Chastain Katherine, Doyle Margaret, Usmani Saad Z
机构信息
Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
出版信息
Blood Cancer J. 2024 Oct 21;14(1):186. doi: 10.1038/s41408-024-01160-1.
Abstract
摘要
Zotero 插件